[HTML] sciencedirect.com

[HTML][HTML] Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer

H Dubey, A Ranjan, J Durai, MA Khan… - Cancer Treatment and …, 2023 - Elsevier
Introduction Uterine cervical cancer (UCC) is the fourth most common health problem
worldwide among women. Currently available biomarkers CA125, CA199, and CEA for …
被引用次数：3 相关文章

Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer.

H Dubey, S Gupta, MA Khan, S Khurana… - Cancer Treatment …, 2022 - europepmc.org
Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer

H Dubey, A Ranjan, J Durai… - Cancer treatment …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Uterine cervical cancer (UCC) is the fourth most common health problem
worldwide among women. Currently available biomarkers CA125, CA199, and CEA for …